A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease
Download from source ↗Dataset overview
A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease.
Abstract
Inflammatory bowel disease (IBD) is a chronic condition caused by altered cytokine signaling, maladaptive immunity, dysbiosis, and intestinal barrier dysfunction. Although current therapies aim to correct these imbalances to induce remission, most patients ultimately relapse, suggesting that key pathogenic mechanisms persist. Here, we identified aberrant epithelial cell death signaling as an underlying feature of IBD that arises in patients in remission and on advanced therapy. Mechanistically, nascent inflammation skewed epithelial cells into an M1-macrophage-like transcriptional state that promoted RIPK1-independent necroptotic signaling. This signaling then triggered inducible nitric oxide synthase-assisted mitochondrial apoptosis of absorptive epithelial cells and PUMA-mediated intestinal stem cell death. Thus, aberrant epithelial cell death signaling represents a hallmark of IBD that occurs early in mucosal lesion development, persists despite current therapeutic strategies, and predicts clinical relapse.
Study facts
- Organism
- Homo sapiens
- Platform
- Xenium
- Age group
- —
- Disease groups
- —
- Anatomical sites
- Ascending colon, Caecum, Sigmoid colon, Rectum, Transverse colon, Terminal ileum, Descending colon
Data availability
- Raw counts
- Processed matrix
- Spatial coordinates
- Histology images
File types
H5PARQUETTIFF
Files and samples
- Sigmoid colon15
- Rectum13
- Ascending colon6
- Terminal ileum6
- Caecum4
- Descending colon4
- Transverse colon3
| Accession | Sample | Tissue | Molecule |
|---|---|---|---|
GSM9736137 |
non-IBD NM044 NONI | Ascending colon | total RNA |
GSM9736138 |
non-IBD NM005 NONI | Caecum | total RNA |
GSM9736139 |
IBD NM032 NONI UC | Sigmoid colon | total RNA |
GSM9736140 |
IBD NM033 NONI CD | Rectum | total RNA |
GSM9736141 |
IBD NM033 MARG CD | Transverse colon | total RNA |
GSM9736142 |
IBD NM056 MARG UC | Sigmoid colon | total RNA |
GSM9736143 |
IBD NM014 INF UC | Sigmoid colon | total RNA |
GSM9736144 |
IBD NM053 INF CD | Terminal ileum | total RNA |
GSM9736145 |
IBD NM032 INF UC | Rectum | total RNA |
GSM9736146 |
IBD NM043 NONI UC | Sigmoid colon | total RNA |
GSM9736147 |
non-IBD NM039 NONI | Ascending colon | total RNA |
GSM9736148 |
non-IBD NM007 NONI | Terminal ileum | total RNA |
GSM9736149 |
IBD NM006 NONI UC | Caecum | total RNA |
GSM9736150 |
IBD NM057 NONI CD | Sigmoid colon | total RNA |
GSM9736151 |
IBD NM060 MARG CD | Rectum | total RNA |
GSM9736152 |
IBD NM006 MARG UC | Caecum | total RNA |
GSM9736153 |
IBD NM006 INF UC | Caecum | total RNA |
GSM9736154 |
IBD NM019 INF CD | Rectum | total RNA |
GSM9736155 |
IBD NM050 INF UC | Rectum | total RNA |
GSM9736156 |
IBD NM017 NONI UC | Sigmoid colon | total RNA |
GSM9736157 |
IBD NM059 NONI UC | Ascending colon | total RNA |
GSM9736158 |
non-IBD NM023 NONI | Sigmoid colon | total RNA |
GSM9736159 |
non-IBD NM010 NONI | Sigmoid colon | total RNA |
GSM9736160 |
IBD NM050 MARG UC | Sigmoid colon | total RNA |
GSM9736161 |
non-IBD NM035 NONI | Ascending colon | total RNA |
GSM9736162 |
non-IBD NM015 NONI | Transverse colon | total RNA |
GSM9736163 |
IBD NM053 NONI CD | Descending colon | total RNA |
GSM9736164 |
IBD NM030 NONI UC | Sigmoid colon | total RNA |
GSM9736165 |
IBD NM029 MARG UC | Sigmoid colon | total RNA |
GSM9736166 |
IBD NM030 MARG UC | Rectum | total RNA |
GSM9736167 |
IBD NM001 INF CD | Terminal ileum | total RNA |
GSM9736168 |
IBD NM030 INF UC | Rectum | total RNA |
GSM9736169 |
IBD NM043 INF UC | Rectum | total RNA |
GSM9736170 |
IBD NM014 NONI UC | Sigmoid colon | total RNA |
GSM9736171 |
IBD NM042 NONI CD | Sigmoid colon | total RNA |
GSM9736172 |
non-IBD NM012 NONI | Ascending colon | total RNA |
GSM9736173 |
non-IBD NM009 NONI | Ascending colon | total RNA |
GSM9736174 |
non-IBD NM034 NONI | Transverse colon | total RNA |
GSM9736175 |
IBD NM029 NONI UC | Descending colon | total RNA |
GSM9736176 |
IBD NM058 NONI CD | Rectum | total RNA |
GSM9736177 |
IBD NM057 MARG CD | Terminal ileum | total RNA |
GSM9736178 |
IBD NM036 MARG UC | Rectum | total RNA |
GSM9736179 |
IBD NM057 INF CD | Terminal ileum | total RNA |
GSM9736180 |
IBD NM036 INF UC | Rectum | total RNA |
GSM9736181 |
IBD NM003 MARG UC | Sigmoid colon | total RNA |
GSM9736182 |
IBD NM003 NONI UC | Descending colon | total RNA |
GSM9736183 |
IBD NM003 NONI UC_THIN | Descending colon | total RNA |
GSM9736184 |
IBD NM017 MARG UC | Sigmoid colon | total RNA |
GSM9736185 |
non-IBD NM049 NONI | Terminal ileum | total RNA |
GSM9736186 |
IBD NM019 MARG CD | Rectum | total RNA |
GSM9736187 |
IBD NM021 INF UC | Rectum | total RNA |
Strengths & limitations for reuse
Strengths
- Raw counts are advertised
- Processed matrices are advertised
- Spatial coordinates are advertised
- Histology images are advertised
Limitations
- Not documented: participant counts are documented
Extraction evidence & provenance
Each extracted field is shown with the source excerpt and location used to resolve it.
Assay
| Field | Value | Evidence |
|---|---|---|
assay.panel_size |
475 |
profile the expression of 475 genes Section |
assay.platform |
Xenium |
mounted directly onto Xenium slides (10x Genomics, Cat#PN-1000460) Section |
assay.platform_version |
Xenium Ranger v4.0.1.1 from source |
Xenium Ranger v4.0.1.1 Section |
assay.resolution |
subcellular |
we used subcellular spatial transcriptomics Section |
assay.segmentation_method |
ProSeg v3.0.10 |
Cells were segmented using ProSeg v3.0.10. Section |
assay.sequencing_based |
False inferred |
re-imported into the original Xenium output bundle using xeniumranger import-segmentation Section |
assay.whole_transcriptome |
False |
subcellular spatial transcriptomics to profile the expression of 475 genes Section |
Cohort
| Field | Value | Evidence |
|---|---|---|
cohort.disease_activity_metadata_available |
True |
51 intestinal biopsies with high RNA integrity were chosen to encompass different degrees of inflammation, intestinal sites, IBD subtypes and treatment classes. Section |
cohort.treatment_exposure_documented |
True from source |
GEO sample characteristics document treatment/therapy Section |
Data_Assets
| Field | Value | Evidence |
|---|---|---|
data_assets.file_manifest |
True |
GSE330953_RAW.tar Section |
data_assets.histology_images |
True from source |
GEO deposit evidence: TIFF in GEO suppfile types Section |
data_assets.molecule_coordinates |
True |
including transcript assignments and cell polygons Section |
data_assets.open_access |
True |
Public on Sep 03 2026 Section |
data_assets.processed_matrix |
True from source |
GEO deposit evidence: H5 in GEO suppfile types Section |
data_assets.raw_counts |
True inferred |
including cell_feature_matrix.h5, cells.parquet, cell_boundaries.parquet, and transcripts.parquet. Section |
data_assets.sample_metadata |
True |
"tissue": "Ascending colon", "study id": "NM044", "ibd status": "Control" Section |
data_assets.segmentation_data |
True |
including transcript assignments and cell polygons Section |
data_assets.spatial_coordinates |
True |
including cell_feature_matrix.h5, cells.parquet, cell_boundaries.parquet, and transcripts.parquet. Section |
Specimens
| Field | Value | Evidence |
|---|---|---|
specimens.anatomical_sites |
['Ascending colon', 'Caecum', 'Sigmoid colon', 'Rectum', 'Transverse colon', 'Terminal ileum', 'Descending colon'] from source |
GEO sample source names: Ascending colon; Caecum; Sigmoid colon; Rectum; Transverse colon; Terminal ileum; Descending colon Section |
specimens.inflamed_status_available |
True from source |
GEO sample characteristics report inflammation status Section |
specimens.number_of_samples |
51 computed |
51 GSM records parsed from GEO family SOFT Section |
specimens.preservation_method |
FFPE |
tissue preservation method: FFPE Section |
specimens.specimen_type |
biopsy |
Here, we used subcellular spatial transcriptomics to profile the expression of 475 genes in intestinal biopsies from patients with or without inflammatory bowel disease (IBD) Section |